Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of sequences of hepatitis C virus NS5A genotype 1 in HIV-coinfected patients with a null response to nitazoxanide or peg-interferon plus ribavirin.

Archives of virology - 1 Sept 2013

Sede M, Laufer N, Ojeda D, Gun A, Cahn P, Quarleri J

Abstract excerpt

Even though new drugs have been approved for treatment of hepatitis C virus (HCV) infection, the risk of drug-drug interactions and concern about overlapping toxicities has hindered the development of studies in HIV/HCV-coinfected individuals. Traditional treatment with pegylated interferon plus ribavirin (peg-IFN + RBV) is very expensive and has a low rate of sustained virological response in coinfected...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Coinfection
Share to Interferons
Share to Nitro Compounds

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polyethylene Glycols

Share to Ribavirin

Share to Thiazoles

Share to Treatment Failure

Share to Viral Nonstructural Proteins

Source

Identifiers

PMID: 23553458
DOI: 10.1007/s00705-013-1687-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of sequences of hepatitis C virus NS5A genotype 1 in HIV-coinfected patients with a null response to nitazoxanide or peg-interferon plus ribavirin.PMID 23553458Read ↗

Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection.Semantic proximity Read ↗

Mutations in the protein kinase-binding domain of the NS5A protein in patients infected with hepatitis C virus type 1a are associated with treatment response.Semantic proximity Read ↗

Analysis of the PKR-eIF2alpha phosphorylation homology domain (PePHD) of hepatitis C virus genotype 1 in HIV-coinfected patients by ultra-deep pyrosequencing and its relationship to responses to pegylated interferon-ribavirin treatment.Semantic proximity Read ↗

Analysis of HCV quasispecies dynamic under selective pressure of combined therapy.Semantic proximity Read ↗

No reduction of HCV viral load in HIV patients co-infected with HCV genotype 1 during a 30 days course of nitazoxanide monotherapy.Semantic proximity Read ↗

No detection of the NS5B S282T mutation in treatment-naïve genotype 1 HCV/HIV-1 coinfected patients using deep sequencing.Semantic proximity Read ↗

Diversity of the hepatitis C virus NS5B gene during HIV co-infection.Semantic proximity Read ↗

Quasispecies evolution in NS5A region of hepatitis C virus genotype 1b during interferon or combined interferon-ribavirin therapy.Semantic proximity Read ↗

Quasispecies of hepatitis C virus genotype 1 and treatment outcome with peginterferon and ribavirin.Semantic proximity Read ↗

Response to interferon-based therapies in HIV-infected patients with chronic hepatitis C due to genotype 4.Semantic proximity Read ↗

HCV antiviral resistance: the impact of in vitro studies on the development of antiviral agents targeting the viral NS5B polymerase.Semantic proximity Read ↗

Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.